Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/CSTONE-PHARMACEUTICALS-57946082/nieuws/CStone-Pharmaceuticals-kondigt-de-vijfde-indicatie-aan-die-is-goedgekeurd-voor-sugemalimab-in-China-46206273/?utm_source=whatsapp&utm_medium=social&utm_campaign=share